Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

BYFC US Equity

Broadway Financial Corp \de\Financials · Savings Institution, Federally Chartered · CIK 1001171 · FY ends Dec 31
$11.91
+0.31 (+2.67%)
USD · as of 2026-08-21 · marketstack

Legal & controls

5 of 5 annual reports readable here

Item 3 and Item 9A as filed · every verdict is the registrant’s own sentence, printed below it · a filing that fails an extraction gate reads “not extracted”

Fiscal yearFiledItem 3ICFRdisclosure controlsmaterial weaknessFiling
2025-12-312026-03-31described hereNOT effectiveNOT effectivedisclosedEDGAR

Item 3 · In the ordinary course of business, we are defendants in various litigation matters from time to time. In our opinion, the disposition of any litigation and other legal and regulatory matters currently pending or threatened against us would not have a material adverse effect on our financial position, results of operations or cash flows.

Item 9A · ICFR · Based on this evaluation, management determined that the Company’s system of internal control over financial reporting was not effective as of December 31, 2025, due to the material weaknesses described below.

Item 9A · disclosure controls · Based on that evaluation, the Company’s PEO and PFO concluded that the Company’s disclosure controls and procedures were not effective as of December 31, 2025 due to material weaknesses in the Company’s internal control over financial reporting, as further described below.

2024-12-312025-03-31described hereeffectiveeffectiveremediated (prior year)EDGAR

Item 3 · In the ordinary course of business, we are defendants in various litigation matters from time to time. In our opinion, the disposition of any litigation and other legal and regulatory matters currently pending or threatened against us would not have a material adverse effect on our financial position, results of operations or cash flows.

Item 9A · ICFR · Based on this evaluation, management determined that the Company’s system of internal control over financial reporting was effective as of December 31, 2024.

Item 9A · disclosure controls · Based on that evaluation, the Company’s PEO and PFO concluded that the Company’s disclosure controls and procedures were effective as of December 31, 2024.

Item 9A · material weakness · Remediation of Previously Identified Material Weakness Management has concluded that the material weakness in internal control over financial reporting initially described in Part I, Item 4 “Controls and Procedures,” of our Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2023 (the “Q3 2023 Form 10-Q”) has been remediated as of December 31, 2024.

2023-12-312024-05-20described hereNOT effectiveNOT effectivedisclosedEDGAR

Item 3 · In the ordinary course of business, we are defendants in various litigation matters from time to time. In our opinion, the disposition of any litigation and other legal and regulatory matters currently pending or threatened against us would not have a material adverse effect on our financial position, results of operations or cash flows.

Item 9A · ICFR · Based on this evaluation, management determined that the Company’s system of internal control over financial reporting was not effective as of December 31, 2023.

Item 9A · disclosure controls · Based on that evaluation, the Company’s PEO and PFO concluded that the Company’s disclosure controls and procedures were not effective as of December 31, 2023 due to a material weakness in the Company’s internal control over financial reporting, as further described below.

2022-12-312023-04-11described hereeffectiveeffectivenone in Item 9AEDGAR

Item 3 · In the ordinary course of business, we are defendants in various litigation matters from time to time. In our opinion, the disposition of any litigation and other legal and regulatory matters currently pending or threatened against us would not have a material adverse effect on our financial position, results of operations or cash flows.

Item 9A · ICFR · Based on this evaluation, management determined that the Company’s system of internal control over financial reporting was effective as of December 31, 2022.

Item 9A · disclosure controls · Based on that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosure controls and procedures were effective as of December 31, 2022.

2021-12-312022-04-15described hereeffectiveeffectivenone in Item 9AEDGAR

Item 3 · On October 5, 2021, purported Company stockholder Sally Nahra filed a complaint against the Company and the members of the pre-Merger board of directors for Broadway in the Superior Court of the State of California in and for the County of Los Angeles. In Nahra v. Bradshaw, No. 21STCV36502, Plaintiff Nahra brings claims of breach of fiduciary duty of candor on behalf of herself and other similarly situated individuals. Plaintiff Nahra alleges that the proxy statement filed with the U.S. Securities and Exchange Commission on February 9, 2021, failed to disclose the personal conflicts of the directors and omitted key financial metrics, and as a result, her shares were diluted and she was deprived of an opportunity to obtain a premium on her investment through potential alternative transactions. Among other remedies, she seeks compensatory and rescissory damages. The Company believes that these claims are without merit and is defending against them vigorously. The Company and the individual defendants have filed a demurrer requesting that the Court dismiss the complaint in its entirety. On March 29, 2022 the court held a hearing on defendant’s demurrer and entered an order sustaining…

Item 9A · ICFR · Based on this evaluation, management determined that the Company’s system of internal control over financial reporting was effective as of December 31, 2021.

Item 9A · disclosure controls · Based on that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosure controls and procedures were effective as of December 31, 2021.

5 of 5 annual reports on record have their filing text cached on this host; the rest are listed with their EDGAR link and no extraction, because this surface never fetches from SEC on a page load.

  • Item 3 and Item 9A are located in the filing HTML already cached on this host and read with the same line-anchored item matcher and largest-gap body disambiguation the filing-narrative pass uses for Item 1A and Item 7 — no fetch, no model, no summarization.
  • A heading is accepted as a section only when it is not a table-of-contents row (a trailing page number), not a quoted reference in prose, and names its own section; the span must then clear a per-item length band and carry readable text after the heading. Anything that fails a gate is served as 'not extracted' with the reason — never as a default value.
  • An effectiveness conclusion is read only from a sentence that names its own control set (disclosure controls and procedures, or internal control over financial reporting) and states an outcome. Conditional sentences — the standard limitations paragraph and forward-looking remediation language — are excluded, because they are hypotheses rather than conclusions.
  • When a filing's own sentences disagree — an effective conclusion beside an unremediated material-weakness disclosure, or two conclusions of opposite sign — no verdict is asserted. A wrong 'controls were effective' reading is worse than no reading.
  • Every verdict is shown beside the verbatim sentence it was read from. The excerpt is the filing's own words, capped at 1,200 characters; the filing itself is one link away.